Detection and treatment of cancers of the colon

Details Detection and treatment of cancers of the colon Detection and treatment of cancers of the colon

2008-01-15

2008-01-15

Ungar, Susan (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C530S350000, C530S387100

Reexamination Certificate

active

07319010

ABSTRACT:
The present invention relates to compositions and methods for cancer therapies and diagnostics, including but not limited to, cancer markers. In particular, the present invention provides tumor antigens associated with specific cancers and diagnostic assays for the detection of such antigens and associated autoantibodies as indicative of the presence of specific cancers. The present invention further provides cancer immunotherapy utilizing the tumor antigens of the present invention.

REFERENCES:
patent: WO 99/10567 (1999-01-01), None
Taber's Cyclopedic Medical Dictionary (1985, F.A. Davis Company, Philadelphia, p. 274).
Krontiris and Capizzi (Internal Medicine, 4th Edition, Editor-in-chief Jay Stein, Elsevier Science, 1994 Chapters 71-72, pp. 699-729).
Greenbaum et al. (Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8).
Brennan et al. (J. Autoimmunity, 1989, 2 (suppl.): 177-186).
Zimmer (Cell Motility and the Cytoskeleton, 1991. 20:325-337).
Hell et al. (Laboratory Investigation, 1995, 73: 492-496).
Fu et al. (EMBO J., 1996, 15:4392-4401).
Vallejo et al. (Biochimie, 2000 82:1129-1133).
Jang et al. (Clinical Exp. Metastasis, 1997, 15: 469-483).
Busken, C et al, (Digestive Disease Week Abstracts and Itinerary Planner, 2003, abstract No. 850).
Stocket et al., “A survey of the humoral immune response of cancer patients to a panel of human tumor antigens,” J. Exp. Med., 187:1349 [1998].
Boon and Old, “Cancer Tumor antigens,” Curr. Opin. Immunol. 9:681 [1997].
Soussl, “p53 Antibodies in the sera of patients with various types of cancer: a review,” Cancer Res. 60:1777 [2000].
Brichory et al., “Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer,” Cancer Research 61, 7908-7912 [2001]).
Old and Chen, “New Paths in Human Cancer Serology,” J. Exp. Med. 187:1163 [1998].
Hibi et al., “PGP9.5 as a candidate tumor marker for non-small-cell lung cancer,” American Journal of Pathology 155, 711-715 [1999].
Kurihara et al., “Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia,” Human Molecular Genetics 10, 1963-1970 [2001].
Tezel et al., “PGP9.5 as a prognostic factor in pancreatic cancer,” Clinical Cancer Research 6, 4764-4767 [2000].
Wada et al., “Cleavage of the C-terminus of NEDD8 by UCH-L3,” Biochem. Biophys. Res. Commun. 251,688-692 [1998].
Proteomics, “Molecular profiling of the immune response in colon cancer using protein microarrays: occurance of autoantibodies to ubiquitin C-terminal hydrolase L3,” Nov. 2003;3(11):2108-15.
Giordano et al., “Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles,” American Journal of Pathology 159, 1231-1238 [2001].
Schwartz et al., “Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas,” Cancer Research 62, 4722-4729 [20.

Affiliated with

Also associated with

Rating

Detection and treatment of cancers of the colon does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection and treatment of cancers of the colon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and treatment of cancers of the colon will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2813169